Dr. Saper is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3120 Professional Dr
Ann Arbor, MI 48104Phone+1 734-677-6000Fax+1 734-677-2422
Education & Training
University of MichiganResidency, Neurology, 1970 - 1973
Michael Reese Hospital and Medical CenterInternship, Internal Medicine, 1969 - 1970
University of Illinois College of MedicineClass of 1969
Certifications & Licensure
MI State Medical License 1971 - 2027
IL State Medical License 1970 - 2017
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2003-2014
- Women's Health Castle Connolly, 2008
- Men's Health Castle Connolly, 2007
Clinical Trials
- Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache. Start of enrollment: 2004 May 01
- Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve Start of enrollment: 2014 Mar 01
- A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache Start of enrollment: 2013 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 18 citationsNon-invasive vagus nerve stimulation for prevention of migraine: The multicenter, randomized, double-blind, sham-controlled PREMIUM II trial.Umer Najib, Timothy Smith, Nada Hindiyeh, Joel Saper, Barbara Nye
Cephalalgia. 2022-06-01 - 218 citationsEptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1).Messoud Ashina, Joel Saper, Roger Cady, Barbara Schaeffler, David M. Biondi
Cephalalgia. 2020-02-19 - 38 citationsSafety of galcanezumab in patients with episodic migraine: A randomized placebo-controlled dose-ranging Phase 2b study:Tina M. Oakes, Vladimir Skljarevski, Qi Zhang, William Kielbasa, Michael E Hodsdon
Cephalalgia. 2018-01-08
Press Mentions
Post Concussion Migraine: How a Head Injury Might Change Your Headache Condition or Result in PhotophobiaFebruary 7th, 2020
My Migraines Keep Coming Back – the Insanity of Medication Overuse Headaches (MOH)October 19th, 2019
Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual MeetingApril 23rd, 2019- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
